IP Library Granted Patent US 12,539,260
Granted Patent B2
US 12,539,260 · App. 17/752,915 · Granted Feb 3, 2026

Antiseptic wipes

Inventors: William Parthun (Lake Forest, IL); Martin Coffey (Buffalo Grove, IL); Alannah Minarcik (Palatine, IL)
Assignee: Medline Industries, LP
A61K8/0208A61K8/34A61K8/416A61K8/43A61K8/891A61Q17/005A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,539,260
App. No.
17/752,915
Granted
Feb 3, 2026
Kind
B2
Abstract

A wipe includes a cleansing composition disposed on a cloth. The cleansing composition can include an antiseptic, a humectant, an emollient, a surfactant, and a monohydric alcohol. A wipe can be made by preparing a cleansing composition and disposing the cleansing composition on a cloth. Two or more wipes may be included in a sealed package to maintain the sterile state of the wipes. A method of disinfecting skin can include applying a wipe to skin.

Claims (20)

1 . A wipe comprising:

a nonwoven cloth comprising plural fibers and having a denier variance ranging from 0.05 to 0.09, and

a cleansing composition disposed on the cloth, the cleansing composition comprising chlorhexidine gluconate in an amount sufficient to reduce the number of active pathogens present on skin upon contact between the cleansing composition and the skin, a monohydric alcohol in an amount effective to provide a defoaming effect, a wetting agent, and water.

2 . The wipe according to claim 1 , the cleansing composition comprising chlorhexidine gluconate, isopropyl alcohol, and benzalkonium chloride.

3 . The wipe according to claim 1 , further comprising dimethicone.

4 . The wipe according to claim 1 , further comprising a humectant.

5 . The wipe according to claim 1 , further comprising an additional surfactant.

6 . The wipe according to claim 5 , the additional surfactant comprising at least one of octoxynol-9 and polysorbate 20.

7 . The wipe according to claim 1 , the cleansing composition consisting essentially of chlorhexidine gluconate, glycerin, propylene glycol, isopropyl alcohol, dimethicone, and benzalkonium chloride.

8 . The wipe according to claim 7 , the cleansing composition consisting essentially of chlorhexidine gluconate in an amount ranging from 1 to 3%, glycerin in an amount ranging from 2 to 8%, propylene glycol in an amount ranging from 0.5 to 3%, isopropyl alcohol in an amount ranging from 0.2 to 0.8%, dimethicone in an amount ranging from 0.1% to 0.4%, benzalkonium chloride in an amount ranging from 0.02 to 0.08%, and water.

9 . The method of disinfecting skin comprising applying the wipe according to claim 1 to skin.

10 . The method according to claim 9 , the method comprising applying the wipe according to claim 1 within eight hours prior to a surgical procedure.

11 . A package comprising a container having contained therewithin at least two wipes according to claim 1 .

12 . A method of making a wipe, the method comprising:

preparing a cleansing composition consisting essentially of chlorhexidine gluconate in an amount ranging from 1 to 3%, glycerin in an amount ranging from 2 to 8%, propylene glycol in an amount ranging from 0.5 to 3%, isopropyl alcohol in an amount ranging from 0.2 to 0.8%, dimethicone in an amount ranging from 0.1% to 0.4%, benzalkonium chloride in an amount ranging from 0.02 to 0.08%, and water; and

introducing the cleansing composition onto a nonwoven cloth having a denier variance ranging from 0.05 to 0.09.

13 . The wipe according to claim 1 , the fibers having a denier ranging from 2.0 to 4.0.

14 . The wipe according to claim 1 , the fibers having a denier ranging from 2.8 to 3.6.

15 . The method according to claim 12 , the cloth having a denier ranging from 2.0 to 4.0.

16 . The method according to claim 12 , the cloth having a denier ranging from 2.8 to 3.6.

Assignments (3)
PATENT SECURITY AGREEMENT Recorded Jan 12, 2026
From: MEDLINE INDUSTRIES, LP F/K/A/ MEDLINE INDUSTRIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 074331/0430 →
PATENT SECURITY AGREEMENT Recorded Jun 20, 2025
From: MEDLINE INDUSTRIES, LP
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 071672/0100 →
SECURITY INTEREST Recorded Apr 2, 2024
From: MEDLINE INDUSTRIES, LP
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 066971/0808 →
Continuity (3)
Continuation 16157263 · Oct 11, 2018
Provisional Application 62571627 · Oct 12, 2017
Related Publication 20220287926A1 · Sep 15, 2022
References Cited (5)
US 5536564A · Noda · 1996 [cited by examiner]
US 20020022660A1 · Jampani · 2002 [cited by examiner]
US 20070228064A1 · Brennan · 2007 [cited by examiner]
US 20090226498A1 · Flugge-Berendes · 2009 [cited by applicant]
US 20170188578A1 · Gundlapalli · 2017 [cited by examiner]